Colibri Heart Valve Initiates International CE Mark-enabling Pilot Study of Second-Generation TAVI System
November 03, 2021 11:52 ET
|
Colibri Heart Valve LLC
LOUISVILLE, CO , Nov. 03, 2021 (GLOBE NEWSWIRE) -- Colibri Heart Valve LLC, a privately held emerging medical device company, today announced the initiation of an international pilot study of the...
Colibri Heart Valve Receives a United States Patent Directed to a Replacement Heart Valve that Includes a Dry Valve Sutured to a Stent Member
September 24, 2019 16:01 ET
|
Colibri Heart Valve, LLC
BROOMFIELD, CO, Sept. 24, 2019 (GLOBE NEWSWIRE) -- Colibri Heart Valve LLC, a privately held emerging medical device company, today announced that U.S. Patent No. 10,390,945 (“the ‘945 Patent”) was...
Colibri Heart Valve to Present One-Year Patient Follow-Up Results from Clinical Feasibility Study of Second-Generation TAVI System at EuroPCR
May 14, 2019 10:00 ET
|
Colibri Heart Valve, LLC
BROOMFIELD, CO , May 14, 2019 (GLOBE NEWSWIRE) -- Colibri Heart Valve LLC, a privately held emerging medical device company, today announced that results from the company’s international,...
Colibri Heart Valve to Present Patient Follow-up Results from Clinical Feasibility Study of Second-Generation TAVI System at TCT
September 19, 2018 14:12 ET
|
Colibri Heart Valve, LLC
BROOMFIELD, CO , Sept. 19, 2018 (GLOBE NEWSWIRE) -- Colibri Heart Valve LLC, a privately held emerging medical device company, today announced that results from the company’s international,...
Colibri Heart Valve Continues Enrollment in Clinical Feasibility Study of Second-Generation TAVI System
May 04, 2018 11:09 ET
|
Colibri Heart Valve, LLC
Broomfield, CO, May 04, 2018 (GLOBE NEWSWIRE) -- Colibri Heart Valve LLC, a privately held emerging medical device company, today announced that the Colibri transcatheter aortic valve implantation...
Colibri Heart Valve Advances Second-Generation TAVI System into Clinical Feasibility Study
March 19, 2018 10:52 ET
|
Colibri Heart Valve, LLC
BROOMFIELD, CO , March 19, 2018 (GLOBE NEWSWIRE) -- Colibri Heart Valve LLC, a privately held emerging medical device company, today announced that the first two patients have been successfully...
Colibri Heart Valve Receives ISO 13485 and EN ISO 13485 Certification
March 03, 2017 10:00 ET
|
Colibri Heart Valve, LLC
BROOMFIELD, CO , March 03, 2017 (GLOBE NEWSWIRE) -- Colibri Heart Valve LLC, a privately held emerging medical device company focused on structural heart applications, announced today that it has...
Colibri Heart Valve Enters Agreement with Venus Medtech to Form Joint Venture to Develop Next-Generation Transcatheter Heart Valve Technologies
September 13, 2016 08:00 ET
|
Colibri Heart Valve, LLC
Broomfield, CO, Sept. 13, 2016 (GLOBE NEWSWIRE) -- Colibri Heart Valve LLC, a privately held emerging medical device company focused on structural heart applications, has entered into definitive...
Colibri Heart Valve Receives European Patent for a Method of Making a Pre-packaged, Sterilized Dry Heart Valve, Pre-mounted on a Delivery Catheter
April 27, 2016 08:00 ET
|
Colibri Heart Valve LLC
BROOMFIELD, CO , April 27, 2016 (GLOBE NEWSWIRE) -- Colibri Heart Valve LLC, a privately held emerging medical device company, has received notification from the European Patent Office that patent...
Colibri Heart Valve Forms a New Entity to Monetize Tissue Processing Technology in Applications Outside of Structural Heart
February 25, 2016 15:00 ET
|
Colibri Heart Valve LLC
BROOMFIELD, CO , Feb. 25, 2016 (GLOBE NEWSWIRE) -- Colibri Heart Valve LLC, a privately held emerging medical device company focused on structural heart applications, announces the formation of a...